Pedro M. S.
- Country
- Portugal
- Department
- N/A
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Efficacy and Safety of Finerenone in Reducing Morbidity and Mortality in Heart Failure Patients with LVEF ≥40% Hospitalized for Acute Decompensated Heart Failure
- Efficacy and Safety Evaluation of XXB750 in Heart Failure Patients with LVEF < 50% on Standard Care Including ACEI/ARB or Sacubitril/Valsartan
Data & Insights
Has run more than one trial at 217 of 721 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the field of cardiology, with particular emphasis on atrial fibrillation management and stroke prevention.
- Cardiac Arrhythmias
- Thromboembolism Prevention
- Systemic Embolism Management
The research focus includes evaluating therapeutic approaches for patients with irregular heartbeat conditions.
Preventive Medicine
This investigator concentrates on preventive strategies in cardiovascular health, particularly for patients at elevated risk of stroke.
- Risk Assessment Protocols
- Preventive Therapeutics
- Cardiovascular Risk Management
Their work encompasses comprehensive approaches to preventing cardiovascular complications in high-risk populations.
Therapeutic Innovation
The investigator's expertise extends to comparative therapeutic research, evaluating novel approaches in anticoagulation therapy.
- Novel Therapeutic Agents
- Clinical Efficacy Studies
- Safety Assessment Protocols
Their research contributes to advancing treatment options in cardiovascular medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.